The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
23andMe Holding Co. COM CL A 90138Q108 1,558 406,913 SH   SOLE   406,913 0 0
Aclaris Therapeutics, Inc. COM 00461U105 21,692 1,258,243 SH   SOLE   1,258,243 0 0
Adagio Therapeutics, Inc. COM 00534A102 6,529 1,431,826 SH   SOLE   1,431,826 0 0
Adicet Bio, Inc. COM 007002108 13,580 680,000 SH   SOLE   680,000 0 0
Compass Therapeutics, Inc. COM 20454B104 6,028 4,400,000 SH   SOLE   4,400,000 0 0
Cue Health Inc. COM 229790100 3,164 490,546 SH   SOLE   490,546 0 0
Cullinan Oncology, Inc. COM 230031106 10,392 992,507 SH   SOLE   992,507 0 0
Enanta Pharmaceuticals, Inc. COM 29251M106 3,007 42,250 SH   SOLE   42,250 0 0
Gemini Therapeutics, Inc. COM 36870G105 3,385 2,435,125 SH   SOLE   2,435,125 0 0
Hims & Hers Health, Inc. COM CL A 433000106 14,428 2,706,922 SH   SOLE   2,706,922 0 0
Kinnate Biopharma Inc. COM 49705R105 9,853 875,001 SH   SOLE   875,001 0 0
Pardes Biosciences Inc COM 69945Q105 67,872 9,400,515 SH   SOLE   9,400,515 0 0
Pharvaris N.V. COM N69605108 619 34,142 SH   SOLE   34,142 0 0
Quantum-Si Incorporated COM CL A 74765K105 10,961 2,342,061 SH   SOLE   2,342,061 0 0
Research Alliance Corp. II COM CL A 760873109 4,880 500,000 SH   SOLE   500,000 0 0
Somalogic, Inc. COM CL A 83444K105 29,886 3,726,472 SH   SOLE   3,726,472 0 0
Theseus Pharmaceuticals, Inc. COM 88369M101 37,043 3,212,732 SH   SOLE   3,212,732 0 0